Guerbet

Guerbet: Q1 2023 Revenue

20 4 2023 08:49:25 提供 Nasdaq GlobeNewswire

Guerbet: 2022 annual results

22 3 2023 09:45:58 提供 Nasdaq GlobeNewswire

Guerbet: 2022 revenue

09 2 2023 08:46:34 提供 Nasdaq GlobeNewswire

Guerbet: 2023 Strategic Priorities

16 1 2023 09:40:42 提供 Nasdaq GlobeNewswire

Guerbet: Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions

11 1 2023 10:46:47 提供 Nasdaq GlobeNewswire

Guerbet: Guerbet announces a change in governance for its Artificial Intelligence projects

03 11 2022 10:04:18 提供 Nasdaq GlobeNewswire

Guerbet: Revenue at September 30, 2022

20 10 2022 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) for a project developing artificial intelligence for the early detection of pancreatic cancer

26 9 2022 09:00:00 提供 Nasdaq GlobeNewswire

Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)

21 9 2022 10:00:00 提供 Nasdaq GlobeNewswire

Guerbet: 2022 half-year results

21 9 2022 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet: Revenue at June 30, 2022

21 7 2022 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet receives EMA acceptance of EluciremTM as the Brand Name for Gadopiclenol

12 6 2022 23:30:00 提供 Nasdaq GlobeNewswire

Guerbet: Q1 2022 revenue

21 4 2022 08:45:00 提供 Nasdaq GlobeNewswire

Guerbet strengthens its Executive Committee with the appointment of Charlotte Bamière, General Counsel

05 4 2022 23:30:00 提供 Nasdaq GlobeNewswire

Guerbet - Gadopiclenol Marketing Authorization dossier submissions accepted for review by EMA and FDA - Priority Review granted by US-FDA March 28, 2022

29 3 2022 09:05:55 提供 Nasdaq GlobeNewswire

Guerbet: 2021 annual results

23 3 2022 09:45:00 提供 Nasdaq GlobeNewswire

Guerbet: Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization

07 3 2022 09:00:48 提供 Nasdaq GlobeNewswire

Guerbet: 2021 revenue

10 2 2022 08:54:31 提供 Nasdaq GlobeNewswire

Guerbet: 2021 Corporate Social Responsibility Gaïa-Index: Guerbet consolidates its position as leader in the “Healthcare” category

04 1 2022 09:02:01 提供 Nasdaq GlobeNewswire

Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol

13 12 2021 22:00:00 提供 Nasdaq GlobeNewswire